Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer

Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer

Saved in:
Bibliographic Details
Published in:Oncotarget Vol. 12; no. 23; pp. 2318 - 2319
Main Authors: O’Shea, Anne E., Clifton, Guy T., Peoples, George E.
Format: Journal Article
Language:English
Published: Impact Journals LLC 09-11-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.27998